This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Articles for Residents  • Alert me on articles by topic

Arch Ophthalmol. 2000;118:572-575.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Xanthomonas maltophilia, previously known as Pseudomonas maltophilia and Stenotrophomonas maltophilia, is a gram-negative motile bacillus that can be isolated from human, animal, and environmental sources.¹ It may cause potentially life-threatening opportunistic systemic infections.^1-2 Most isolates demonstrate multidrug resistance, making it a highly virulent organism. Postoperative endophthalmitis caused by X maltophilia is rare. To date, only 2 case reports have been published.^3-4 We describe 4 additional patients with postoperative X maltophilia endophthalmitis treated between January 1, 1996, and March 31, 1999, at the Bascom Palmer Eye Institute, Miami, Fla (Table 1).

Table appears in full text version. Table 1. Treatment Outcomes of Xanthomonas maltophilia Endophthalmitis*

Report of Cases

Case 1

An 80-year-old woman was evaluated for increasing pain and decreased vision in the left eye, 2 weeks after uneventful clear-corneal phacoemulsification and posterior chamber intraocular lens (IOL) insertion. Her medical history was unremarkable. Visual acuity in the affected eye was hand movements. Clinical findings included a 5% hypopyon . . . [Full Text of this Article]

Case 2

Case 3

Case 4

Comment
Corresponding author: Harry W. Flynn, Jr, MD, Bascom Palmer Eye Institute, 900 NW 17th St, Miami, FL 33136 (e-mail: hflynn@miami.med.edu).